AZTA
Price
$30.30
Change
+$0.78 (+2.64%)
Updated
Sep 5 closing price
Capitalization
1.39B
73 days until earnings call
NEPH
Price
$3.83
Change
-$0.16 (-4.01%)
Updated
Sep 5 closing price
Capitalization
40.6M
61 days until earnings call
Interact to see
Advertisement

AZTA vs NEPH

Header iconAZTA vs NEPH Comparison
Open Charts AZTA vs NEPHBanner chart's image
Azenta
Price$30.30
Change+$0.78 (+2.64%)
Volume$525.64K
Capitalization1.39B
Nephros
Price$3.83
Change-$0.16 (-4.01%)
Volume$14.89K
Capitalization40.6M
AZTA vs NEPH Comparison Chart in %
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. NEPH commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a StrongBuy and NEPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (AZTA: $30.30 vs. NEPH: $3.83)
Brand notoriety: AZTA and NEPH are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AZTA: 83% vs. NEPH: 37%
Market capitalization -- AZTA: $1.39B vs. NEPH: $40.6M
AZTA [@Pharmaceuticals: Other] is valued at $1.39B. NEPH’s [@Pharmaceuticals: Other] market capitalization is $40.6M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $162.93B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileNEPH’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • NEPH’s FA Score: 0 green, 5 red.
According to our system of comparison, NEPH is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 4 TA indicator(s) are bullish while NEPH’s TA Score has 5 bullish TA indicator(s).

  • AZTA’s TA Score: 4 bullish, 3 bearish.
  • NEPH’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than NEPH.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а -0.79% price change this week, while NEPH (@Pharmaceuticals: Other) price change was +2.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Reported Earning Dates

AZTA is expected to report earnings on Nov 18, 2025.

NEPH is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($1.39B) has a higher market cap than NEPH($40.6M). NEPH YTD gains are higher at: 160.544 vs. AZTA (-39.400). AZTA has higher annual earnings (EBITDA): 11.3M vs. NEPH (1.49M). AZTA has more cash in the bank: 319M vs. NEPH (5.07M). NEPH has less debt than AZTA: NEPH (1.24M) vs AZTA (52.6M). AZTA has higher revenues than NEPH: AZTA (669M) vs NEPH (16.7M).
AZTANEPHAZTA / NEPH
Capitalization1.39B40.6M3,421%
EBITDA11.3M1.49M756%
Gain YTD-39.400160.544-25%
P/E RatioN/A33.29-
Revenue669M16.7M4,006%
Total Cash319M5.07M6,287%
Total Debt52.6M1.24M4,239%
FUNDAMENTALS RATINGS
AZTA vs NEPH: Fundamental Ratings
AZTA
NEPH
OUTLOOK RATING
1..100
6675
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
66
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9453
PRICE GROWTH RATING
1..100
6236
P/E GROWTH RATING
1..100
56100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEPH's Valuation (66) in the null industry is in the same range as AZTA (70) in the Electronic Production Equipment industry. This means that NEPH’s stock grew similarly to AZTA’s over the last 12 months.

NEPH's Profit vs Risk Rating (100) in the null industry is in the same range as AZTA (100) in the Electronic Production Equipment industry. This means that NEPH’s stock grew similarly to AZTA’s over the last 12 months.

NEPH's SMR Rating (53) in the null industry is somewhat better than the same rating for AZTA (94) in the Electronic Production Equipment industry. This means that NEPH’s stock grew somewhat faster than AZTA’s over the last 12 months.

NEPH's Price Growth Rating (36) in the null industry is in the same range as AZTA (62) in the Electronic Production Equipment industry. This means that NEPH’s stock grew similarly to AZTA’s over the last 12 months.

AZTA's P/E Growth Rating (56) in the Electronic Production Equipment industry is somewhat better than the same rating for NEPH (100) in the null industry. This means that AZTA’s stock grew somewhat faster than NEPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTANEPH
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 13 days ago
75%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PLUR5.020.17
+3.51%
Pluri
NOW913.8015.24
+1.70%
SERVICENOW
LCTX1.220.02
+1.67%
Lineage Cell Therapeutics
PB68.03-0.77
-1.12%
Prosperity Bancshares
VRTS193.98-2.82
-1.43%
Virtus Investment Partners

NEPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with SGHT. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then SGHT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
-4.13%
SGHT - NEPH
34%
Loosely correlated
-1.07%
IMDX - NEPH
31%
Poorly correlated
+0.40%
GH - NEPH
28%
Poorly correlated
-2.00%
AZTA - NEPH
25%
Poorly correlated
+2.64%
NEO - NEPH
24%
Poorly correlated
-0.99%
More